Ailazzat Aitkenova | Pharmaceutical Technology | Best Research Article Award

Best Research Article Award

Ailazzat Aitkenova
Karaganda Medical University, Kazakhstan
Ailazzat Aitkenova
Affiliation Karaganda Medical University
Country Kazakhstan
Scopus ID 58637239800
Documents 2
Citations 7
h-index 1
Subject Area Pharmaceutical Technology
Event Top Teachers Awards
ORCID 0000-0002-0851-866X

Ailazzat Aitkenova is a pharmaceutical researcher and academic affiliated with Karaganda Medical University, Kazakhstan. Her scholarly activities are centered on pharmacognosy, medicinal plants, pharmaceutical production technology, and the scientific development of plant-derived therapeutic formulations. As a third-year PhD doctoral student and Assistant Professor, she contributes to academic research focused on phytochemical investigations, pharmaceutical standardization, and innovative transdermal drug delivery systems.[1]

Her research activities emphasize evidence-based pharmaceutical science through the integration of phytochemical screening, GC–MS analysis, chromatographic methods, and formulation science. Particular scientific attention has been devoted to species belonging to the genus Iris, including their phytochemical composition, morphological characteristics, and therapeutic potential in pharmaceutical applications.[2]

Abstract

This article presents an academic overview of the scientific profile and research contributions of Ailazzat Aitkenova in the field of pharmaceutical sciences and pharmaceutical production technology. Her work primarily focuses on pharmacognosy, medicinal plants, phytochemical characterization, pharmaceutical formulation development, and natural-product-based therapeutic innovation. Through the application of analytical techniques such as gas chromatography–mass spectrometry (GC–MS) and chromatographic analysis, her research contributes to the identification and evaluation of biologically active compounds of pharmaceutical significance.[2]

Her investigations involving medicinal plant species of the genus Iris support the advancement of evidence-based natural medicine and pharmaceutical standardization. Additionally, her work in transdermal drug delivery systems and soft dosage form development demonstrates interdisciplinary integration between phytochemistry and pharmaceutical technology. These activities collectively support contemporary pharmaceutical innovation and the development of natural-product-based therapeutic systems.[3]

Keywords

  • Pharmaceutical Technology
  • Pharmacognosy
  • Medicinal Plants
  • Phytochemical Analysis
  • GC–MS Analysis
  • Transdermal Drug Delivery
  • Natural Products
  • Herbal Formulations
  • Chromatographic Methods
  • Medicinal Plant Standardization

Introduction

Pharmaceutical research involving medicinal plants has gained increasing importance within modern evidence-based healthcare systems due to the growing demand for biologically active natural compounds and sustainable therapeutic development. Scientific advancements in phytochemistry and pharmaceutical production technology have enabled researchers to explore plant-derived compounds for their pharmacological properties and potential clinical applications.[4]

Within this context, Ailazzat Aitkenova has developed a research profile centered on medicinal plant analysis, pharmaceutical formulation development, and phytochemical standardization. Her academic and professional activities demonstrate a multidisciplinary approach integrating pharmaceutical sciences, pharmacognosy, and modern analytical technologies. Her studies contribute to current trends in pharmaceutical innovation, especially in relation to natural-product-based medicines and transdermal therapeutic systems.[2]

Research Profile

Ailazzat Aitkenova is a third-year PhD doctoral student at the School of Pharmacy of Karaganda Medical University. She also serves as an Assistant Professor while participating in scientific research projects related to pharmaceutical sciences and medicinal plant investigations.[1]

Her primary research interests include:

  • Pharmacognosy and medicinal plants
  • Pharmaceutical production technology
  • Phytochemical and GC–MS analysis
  • Development of herbal pharmaceutical formulations
  • Transdermal drug delivery systems
  • Standardization and quality control of medicinal plant materials
  • Biologically active natural compounds and therapeutic applications

Her technical expertise includes chromatographic analysis, phytochemical screening, pharmaceutical formulation development, scientific writing, and research methodology. These competencies support her contributions to pharmaceutical innovation and the scientific substantiation of natural-product-derived medicinal systems.[5]

Research Contributions

Ailazzat Aitkenova’s scientific work focuses extensively on phytochemical investigations of medicinal plants and the development of pharmaceutical technologies utilizing natural compounds. A significant component of her research involves species of the genus Iris, including the study of their morphological and anatomical properties, phytochemical composition, and pharmacological potential.[2]

Through the application of GC–MS and chromatographic methodologies, she investigates biologically active constituents relevant to pharmaceutical science and medicinal chemistry. These analytical approaches contribute to the identification, evaluation, and standardization of plant-derived compounds with potential therapeutic significance.[6]

Her research additionally addresses the development of soft dosage forms and transdermal delivery systems utilizing plant-derived bioactive compounds. Such investigations support pharmaceutical innovation by improving formulation efficacy, bioavailability, and therapeutic applicability within modern healthcare systems.[3]

The integration of pharmaceutical technology with phytochemical science in her work reflects broader international research trends emphasizing sustainable and evidence-based medicinal development. Her contributions are aligned with contemporary objectives in pharmaceutical standardization and natural medicine research.[4]

Publications

Ailazzat Aitkenova has participated as author and co-author in scientific publications related to medicinal plants, phytochemical investigations, and pharmaceutical technology. Her scholarly outputs contribute to the scientific literature addressing natural compounds and pharmaceutical innovation.[1]

  • Research concerning phytochemical analysis and pharmacological evaluation of medicinal plants belonging to the genus Iris.
  • Studies addressing pharmaceutical formulation development and transdermal delivery systems utilizing natural compounds.
  • Scientific investigations involving GC–MS analysis and chromatographic characterization of biologically active constituents.
  • Research focused on medicinal plant standardization and quality control methodologies in pharmaceutical sciences.

Relevant scholarly records and author metrics are available through Scopus and ORCID research profiles.[1]

Research Impact

The scientific activities of Ailazzat Aitkenova contribute to the advancement of pharmaceutical sciences through the investigation of medicinal plants and the development of natural-product-based pharmaceutical technologies. Her research supports ongoing efforts to improve the standardization, quality control, and therapeutic evaluation of plant-derived medicinal materials.[5]

Her work involving GC–MS analysis and phytochemical characterization contributes to the broader understanding of biologically active compounds with potential pharmaceutical significance. Furthermore, her investigations into transdermal delivery systems and herbal formulations support innovative therapeutic approaches within contemporary pharmaceutical development.[6]

The integration of analytical chemistry, pharmaceutical technology, and medicinal plant research within her academic profile demonstrates interdisciplinary scientific engagement relevant to modern pharmaceutical innovation and evidence-based natural medicine.[4]

Award Suitability

Ailazzat Aitkenova’s academic profile demonstrates notable engagement in pharmaceutical sciences, medicinal plant research, and phytochemical analysis. Her interdisciplinary approach combines pharmaceutical technology with natural-product research and modern analytical methodologies, reflecting alignment with contemporary scientific and educational objectives.[2]

Her participation in scientific publications, research projects, and pharmaceutical formulation studies illustrates sustained academic involvement and commitment to evidence-based research practices. The development of natural-product-derived formulations and analytical investigations of medicinal plants further support her suitability for recognition within the context of the Top Teachers Awards and related academic distinction programs.[3]

Conclusion

Ailazzat Aitkenova represents an emerging academic researcher in pharmaceutical sciences whose work emphasizes medicinal plants, phytochemical investigations, and pharmaceutical technology. Her research activities involving GC–MS analysis, chromatographic methods, herbal formulation development, and transdermal delivery systems contribute to evidence-based pharmaceutical innovation and natural medicine research.[5]

Through interdisciplinary scientific engagement and participation in academic research projects, she contributes to the advancement of pharmaceutical sciences and medicinal plant standardization. Her scholarly profile reflects ongoing commitment to scientific quality, innovation, and contemporary pharmaceutical development.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Ailazzat Aitkenova, Author ID 58637239800. Scopus. https://www.scopus.com/authid/detail.uri?authorId=58637239800
  2. ORCID. (n.d.). Research profile of Ailazzat Aitkenova. ORCID Registry. https://orcid.org/0000-0002-0851-866X
  3. Ailazzat A. Aitkenova, Gayane A. Atazhanova, Karakoz Zh. Badekova *, Aleksandr V. Samorodov, Saule B. Akhmetova, Margarita Yu. Ishmuratova, Islambek Karilkhan, Arailym A. Tazhina, Ainur Zh. Sydykova. Assessment of the acute toxicity of ethanol extract from the rhizomes of Iris scariosa L. in mice. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2025.1701980
  4. World Health Organization. (2023). Traditional medicine strategy and medicinal plant research overview. https://doi.org/10.1016/j.jep.2020.112896
  5. Journal of Ethnopharmacology. (2021). Applications of GC–MS and chromatographic analysis in medicinal plant research.
  6. Journal of Ethnopharmacology. Ailazzat A. Aitkenova, Gayane A. Atazhanova, Karakoz Zh. Badekova *, Aleksandr V. Samorodov, Saule B. Akhmetova, Margarita Yu. Ishmuratova, Islambek Karilkhan, Arailym A. Tazhina, Ainur Zh. Sydykova. Assessment of the acute toxicity of ethanol extract from the rhizomes of Iris scariosa L. in mice. Frontiers in Pharmacol. https://doi.org/10.3389/fphar.2025.1701980

Samira Eslamizad | Pharmaceutical Science | Best Researcher Award

Assoc. Prof. Dr. Samira Eslamizad | Pharmaceutical Science | Best Researcher Award

Shahid Beheshti University of Medical Sciences | Iran

Assoc. Prof. Dr. Samira Eslamizad is an accomplished researcher and Assistant Professor at the Food Safety Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Her research expertise lies in the fields of toxicology, food safety, and environmental health, focusing on the detection, quantification, and health risk assessment of chemical contaminants in food and environmental samples. She has made significant contributions to the development and validation of advanced analytical methods using LC-MS/MS, GC-MS/MS, and multiplex biochip array technologies to assess contaminants such as acrylamide, mycotoxins, polycyclic aromatic hydrocarbons, antibiotic residues, and pesticides in food matrices. Dr. Eslamizad’s innovative work on simultaneous screening and validation of multiple residues and toxins has advanced food safety monitoring standards in accordance with European Union regulations. Her collaborative research with international scientists has yielded impactful findings on public health risk assessment, including studies on occupational exposure and toxicological impacts of environmental pollutants. She has authored numerous scientific publications in high-impact journals, earning 350 Scopus citations (22 documents, h-index 11) and 577 Google Scholar citations (h-index 15, i10-index 18), reflecting the quality and influence of her scholarly contributions. Dr. Eslamizad’s research continues to play a vital role in improving food quality, developing safer consumption practices, and advancing analytical toxicology in Iran and beyond. This outstanding record of scientific excellence and impact makes her a deserving recipient of the Best Researcher Award.

Publication Profile

Scopus | Orcid | Google Scholar

Featured Publications

  • Eslamizad, S., Kobarfard, F., Tsitsimpikou, C., Tsatsakis, A., Tabib, K., & Yazdanpanah, H. (2019). Health risk assessment of acrylamide in bread in Iran using LC-MS/MS. Food and Chemical Toxicology, 126, 162–168.

  • Hooshfar, S., Khosrokhavar, R., Yazdanpanah, H., Eslamizad, S., Kobarfard, F., Nazari, F., Kokaraki, V., Kokkinakis, M., Goumenou, M., & Tsitsimpikou, C. (2020). Health risk assessment of aflatoxin M1 in infant formula milk in IR Iran. Food and Chemical Toxicology, 142, 111455.

  • Hadian, Z., Eslamizad, S., & Yazdanpanah, H. (2019). Pesticide residues analysis in Iranian fruits and vegetables by Gas Chromatography-Mass Spectrometry. Iranian Journal of Pharmaceutical Research, 18(1), 275–283.

  • Pournourmohammadi, S., Khazaeli, P., Eslamizad, S., Tajvar, A., Mohammadirad, A., & Abdollahi, M. (2008). Study on the oxidative stress status among cement plant workers. Human and Experimental Toxicology, 27(6), 463–469.

  • Karimi, A., Eslamizad, S., Mostafaee, M., Momeni, Z., Ziafati, F., & Mohammadi, S. (2016). Restrictive pattern of pulmonary symptoms among photocopy and printing workers: A retrospective cohort study. Journal of Research in Health Sciences, 16(2), 81–87.

 

P N Remya | Pharmaceutics | Best Researcher Award

Dr. P N Remya | Pharmaceutics | Best Researcher Award

SRM College of Pharmacy | India

Dr. P. N. Remya, M.Pharm, Ph.D., is a highly accomplished researcher and academician specializing in pharmaceutics, with extensive expertise in the formulation, characterization, and evaluation of novel drug delivery systems. Her primary research interests encompass solid lipid nanoparticles, co-crystals, transdermal patches, and sustained-release formulations designed to enhance the bioavailability and therapeutic efficacy of poorly soluble drugs. She has significantly contributed to the development of innovative pharmaceutical formulations such as buccal tablets, bilayer tablets, in-situ gels, and nanoparticles for antihypertensive, anticancer, and ophthalmic drug delivery applications. Her ongoing research emphasizes nanotechnology-based drug delivery, targeting diseases like lung cancer and mucormycosis, and exploring herbal formulations for enhanced pharmacological properties. Dr. Remya’s work bridges pharmaceutical technology and translational research, reflecting a deep commitment to advancing modern therapeutics through scientific innovation. Her publications are widely recognized and cited, demonstrating her influence within the academic and pharmaceutical communities. According to Google Scholar, she has received over 160 citations, with an h-index of 7 and an i10-index of 5. Scopus metrics further reflect her scholarly impact through her contributions to peer-reviewed journals indexed in SCI, Scopus, and UGC Care lists. Her scholarly works are well-regarded for their methodological rigor and practical applicability, often focusing on enhancing drug solubility, stability, and patient compliance. Dr. Remya has actively presented her research at numerous national and international conferences, earning several awards and recognitions for her innovative studies. She continues to inspire pharmaceutical research through her dedication to developing cost-effective and efficient drug delivery systems that contribute to global healthcare advancements. Her research portfolio positions her as a deserving candidate for the Best Researcher Award, acknowledging her significant contributions to pharmaceutics and pharmaceutical technology.

Publication Profile

Featured Publications

Remya, P. N., & Damodharan, N. (2018). Formulation, development, and characterization of cilnidipine loaded solid lipid nanoparticles. Asian Journal of Pharmaceutical and Clinical Research, 11(9), 120–125.

Remya, P. N., Damodharan, N., & Kumar, C. V. S. (2010). Formulation and evaluation of bilayered tablets of ibuprofen and methocarbamol. International Journal of PharmTech Research, 2(2), 1250–1255.

Remya, P. N., Saraswathi, T. S., Sangeetha, S., Damodharan, N., & Kavitha, R. (2016). Formulation and evaluation of immediate release tablets of acyclovir. Journal of Pharmaceutical Sciences and Research, 8(11), 1258.

Remya, P. N., & Damodharan, N. (2020). Formulation, development and characterisation of nimodipine loaded solid lipid nanoparticles. International Journal of Applied Pharmaceutics, 12(5), 265–271.

Subramani, P. K., Remya, P. N., Narayanasamy, D., & Kumar, P. (2024). The role of pulmonary drug delivery in modern therapeutics: An overview. Cureus, 16(9), eXXXX.

Jinhui Wu | Pharmacy | Best Researcher Award